Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-16

Clinical Trial Update: Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the methylphenidate transdermal system for adults with ADHD has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate Transdermal System (methylphenidate)

Snippet

Sponsor: University of Utah | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2015-01-16